ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

No reported Cash & Equivalents figures are available to summarize.

Cash & Equivalents history

Currency unavailable · from the balance sheet

No Cash & Equivalents data reported for this period type.

Cash & Equivalents vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Cash & Equivalents for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
WVEWave Life Sciences Ltd.Mar 2026$544.59M USD+124.0%+89.5%93.3%
RNAAtrium Therapeutics, Inc.Mar 2026$267.85M USD——91.6%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$211.38M USD-2.6%-16.2%86.1%
BNTCBenitec Biopharma Inc.Mar 2026$184.76M USD+78.4%+188.7%98.8%
STOKStoke Therapeutics, Inc.Mar 2026$155.66M USD-43.4%-9.5%35.1%
PRQRProQR Therapeutics N.V.Mar 2026€81.17M EUR-43.2%-0.9%81.9%
MGTXMeiraGTx Holdings plcMar 2026$71.54M USD+7.5%-17.1%29.2%
PRMEPrime Medicine, Inc.Mar 2026$64.11M USD-30.2%-30.5%21.8%
SLNSilence Therapeutics plcMar 2026$5.66M USD-91.3%-41.0%4.9%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-16.4%-12.8%81.9%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.